Cited by 2,577Alzheimer's disease research and treatmentsDementia and Cognitive Impairment ResearchNeuroinflammation and Neurodegeneration Mechanisms

The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.

Candidate gene for the chromosome 1 familial Alzheimer’s disease locus

Levy-Lahad, Ephrat, Wasco, Wilma, Poorkaj, Parvoneh, Romano, Donna M., Oshima, Junko, Pettingell, Warren H., Yu, Chang-en, Jondro, Paul D., Schmidt, Stephen D., Wang, Kai, Crowley, Annette C., Fu, Ying-Hui, Guenette, Suzanne Y., Galas, David, Nemens, Ellen, Wijsman, Ellen M., Bird, Thomas D., Schellenberg, Gerard D., Tanzi, Rudolph E.·1995·Science

DOI 10.1126/science.7638622

Open this paper in CoChat — free account

Abstract

A candidate gene for the chromosome 1 Alzheimer's disease (AD) locus was identified (STM2). The predicted amino acid sequence for STM2 is homologous to that of the recently cloned chromosome 14 AD gene (S182). A point mutation in STM2, resulting in the substitution of an isoleucine for an asparagine (N141l), was identified in affected people from Volga German AD kindreds. This N141l mutation occurs at an amino acid residue that is conserved in human S182 and in the mouse S182 homolog. The presence of missense mutations in AD subjects in two highly similar genes strongly supports the hypothesis that mutations in both are pathogenic.

Integrity signals

Registry

Crossref · 10.1126/science.7638622

Cites

25 of 25 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Gene Dose of Apolipoprotein E Type 4 Allele and the Risk of Alzheimer's Disease in Late Onset Families
Corder, E. H., Saunders, A. M., Strittmatter, W. J., Schmechel, D. E., Gaskell, P. C., Small, G. W., Roses, A. D., Haines, J. L., & Pericak-Vance, M. A. (1993) · Science · doi:10.1126/science.8346443 · Cited by 9,429
Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease
Goate, A., Chartier-Harlin, M.-C., Mullan, M., Brown, J., Crawford, F., Fidani, L., Giuffra, L., Haynes, A., Irving, N., James, L., et al. (1991) · Nature · doi:10.1038/349704a0 · Cited by 4,659
Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease
Sherrington, R., Rogaev, E. I., Liang, Y., Rogaeva, E. A., Levesque, G., Ikeda, M., Chi, H., Lin, C., Li, G., Holman, K., et al. (1995) · Nature · doi:10.1038/375754a0 · Cited by 4,051
Self-citation
Early-onset Alzheimer's disease caused by mutations at codon 717 of the β-amyloid precursor protein gene
Chartier-Harlin, M.-C., Crawford, F., Houlden, H., Warren, A., Hughes, D., Fidani, L., Goate, A., Rossor, M., Roques, P., Hardy, J., et al. (1991) · Nature · doi:10.1038/353844a0 · Cited by 1,214
A mutation in the Amyloid Precursor Protein Associated with Hereditary Alzheimer's Disease
Murrell, J. R., Farlow, M. R., Ghetti, B. F., & Benson, M. D. (1991) · Science · doi:10.1126/science.1925564 · Cited by 1,142
Genetic Linkage Evidence for a Familial Alzheimer's Disease Locus on Chromosome 14
Schellenberg, G. D., Bird, T. D., Wijsman, E. M., Orr, H. T., Anderson, L., Nemens, E. J., White, J. A., Bonnycastle, L. L., Weber, J. L., Alonso, M. E., et al. (1992) · Science · doi:10.1126/science.1411576 · Cited by 957
Self-citation
A Familial Alzheimer's Disease Locus on Chromosome 1
Levy‐Lahad, E., Wijsman, E. M., Nemens, E. J., Anderson, L., Goddard, K. A. B., Weber, J. L., Bird, T. D., & Schellenberg, G. D. (1995) · Science · doi:10.1126/science.7638621 · Cited by 832
Self-citation
Effects of Misspecifying Genetic Parameters in Lod Score Analysis
Clerget‐Darpoux, F., Bonaïti‐Pellié, C., & Hochez, J. (1986) · Biometrics · doi:10.2307/2531059 · Cited by 439
A locus for familial early–onset Alzhelmer's disease on the long arm of chromosome 14, proximal to the α1–antichymotrypsin gene
Mullan, M., Houlden, H., Windelspecht, M., Fidani, L., Lombardi, C., Diaz, P., Rossor, M. N., Crook, R., Hardy, J., Duff, K., et al. (1992) · Nature Genetics · doi:10.1038/ng1292-340 · Cited by 277
Linkage and mutational analysis of familial Alzheimer disease kindreds for the APP gene region.
Kamino, K., Orr, H. T., Payami, H., Wijsman, E. M., Alonso, M. E., Pulst, S. M., Anderson, L., O'dahl, S., Nemens, E. J., & White, J. A. (1992) · PubMed · Cited by 270
Self-citation

Flagged first, then by citations

Show all 25 references

Research works printed but not linked: 3

Bird, T. D., Journal of the American Historical Society of Germans from Russia 49: 1 (1991).
Scheuner D. Soc. Neurosci. Abstr. in press.
Song X.-H. Soc. Neurosci. Abstr. in press.

Sorted by citations

Items 501–600 of 1,015

The hemochromatosis gene affects the age of onset of sporadic Alzheimer’s disease
Sampietro, M., Caputo, L., Casatta, A., Meregalli, M., Pellagatti, A., Tagliabue, J., Annoni, G., & Vergani, C. (2001) · Neurobiology of Aging · doi:10.1016/s0197-4580(01)00219-6 · Cited by 111
Management of Alzheimer's Disease
Grossberg, G. T., & Desai, A. K. (2003) · The Journals of Gerontology Series A · doi:10.1093/gerona/58.4.m331 · Cited by 110
Fatty acids, lipid metabolism and Alzheimer pathology
Hooijmans, C. R., & Kiliaan, A. J. (2008) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2007.11.081 · Cited by 115
The Pathogenesis of Alzheimer′s Disease: A Reevaluation of the “Amyloid Cascade Hypothesis”
Armstrong, R. A. (2011) · International Journal of Alzheimer s Disease · doi:10.4061/2011/630865 · Cited by 117
Up-Regulation of Calcineurin Aβ mRNA in the Alzheimer's Disease Brain: Assessment by cDNA Microarray
Hata, R., Masumura, M., Akatsu, H., Li, F., Fujita, H., Nagai, Y., Yamamoto, T., Okada, H., Kosaka, K., Sakanaka, M., et al. (2001) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.4968 · Cited by 109
Familial Alzheimer's chromosome 14 mutations
Wasco, W., Pettingell, W. P., Jondro, P. D., Schmidt, S. D., Gurubhagavatula, S., Rodes, L., Di-Blasi, T., Romano, D., Guénette, S. Y., Kovacs, D. M., et al. (1995) · Nature Medicine · doi:10.1038/nm0995-848a · Cited by 109
Self-citation
Preimplantation Diagnosis for Early-Onset Alzheimer Disease Caused by V717L Mutation
Verlinsky, Y. (2002) · JAMA · doi:10.1001/jama.287.8.1018 · Cited by 109
Cellular Regulation of Amyloid Formation in Aging and Disease
Stroo, E., Koopman, M., Nollen, E. A. A., & Mata‐Cabana, A. (2017) · Frontiers in Neuroscience · doi:10.3389/fnins.2017.00064 · Cited by 119
What Can We Learn About Human Disease from the Nematode C. elegans?
Apfeld, J., & Alper, S. (2018) · Methods in molecular biology · doi:10.1007/978-1-4939-7471-9_4 · Cited by 116
Transcriptional regulation of APH‐1A and increased γ‐secretase cleavage of APP and Notch by HIF‐1 and hypoxia
Wang, R., Zhang, Y., Zhang, X., Liu, R., Zhang, X., Hong, S., Xia, K., Xia, J., Zhang, Z., & Xu, H. (2006) · The FASEB Journal · doi:10.1096/fj.06-5839fje · Cited by 112
Stereologic assessment of the total cortical volume occupied by amyloid deposits and its relationship with cognitive status in aging and Alzheimer’s disease
Bussière, T., Friend, P. D., Sadeghi, N., Wicinski, B. A., Lin, G. I., Bouras, C., Giannakopoulos, P., Robakis, N. K. R. K., Morrison, J. H., Perl, D. P., et al. (2002) · Neuroscience · doi:10.1016/s0306-4522(02)00056-8 · Cited by 108
Genes, models and Alzheimer's disease
Chapman, P. F., Falinska, A. M., Knevett, S. G., & Ramsay, M. F. (2001) · Trends in Genetics · doi:10.1016/s0168-9525(01)02285-5 · Cited by 108
Alzheimer Aβ neurotoxicity: Promotion by antichymotrypsin, ApoE4; inhibition by Aβ-related peptides
Ma, J., Brewer, H. B., & Potter, H. (1996) · Neurobiology of Aging · doi:10.1016/0197-4580(96)00112-1 · Cited by 108
Synaptic Dysfunction in Alzheimer’s Disease
Marcello, E. E., Epis, R., Saraceno, C., & Luca, M. D. (2012) · Advances in experimental medicine and biology · doi:10.1007/978-3-7091-0932-8_25 · Cited by 115
Amyloid precursor protein and alpha synuclein translation, implications for iron and inflammation in neurodegenerative diseases
Cahill, C. M., Lahiri, D. K., Huang, X., & Rogers, J. T. (2008) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2008.12.001 · Cited by 108
Impact of DNA Testing for Early-Onset Familial Alzheimer Disease and Frontotemporal Dementia
Steinbart, E. J. (2001) · Archives of Neurology · doi:10.1001/archneur.58.11.1828 · Cited by 107
Generation of Anti-apoptotic Presenilin-2 Polypeptides by Alternative Transcription, Proteolysis, and Caspase-3 Cleavage
Vito, P., Ghayur, T., & D'adamio, L. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.45.28315 · Cited by 107
Proteolytic processing of the Alzheimer disease-associated presenilin-1 generates an in vivo substrate for protein kinase C
Walter, J., Grünberg, J., Capell, A., Pesold, B., Schindzielorz, A., Citron, M., Mendla, K. D., George‐Hyslop, P. S., Multhaup, G., Selkoe, D. J., et al. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.10.5349 · Cited by 107
C Terminus of Presenilin Is Required for Overproduction of Amyloidogenic Aβ42 through Stabilization and Endoproteolysis of Presenilin
Tomita, T., Takikawa, R., Koyama, A., Morohashi, Y., Takasugi, N., Saido, T. C., Maruyama, K., & Iwatsubo, T. (1999) · Journal of Neuroscience · doi:10.1523/jneurosci.19-24-10627.1999 · Cited by 106
Interaction of Alzheimer's Presenilin-1 and Presenilin-2 with Bcl-XL
Passer, B. J., Pellegrini, L., Vito, P., Ganjei, J. K., & D'adamio, L. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.34.24007 · Cited by 107
Mutations in presenilin 2 and its implications in Alzheimer’s disease and other dementia-associated disorders
An, S. S. A., Cai, Y., & Kim, S. (2015) · Clinical Interventions in Aging · doi:10.2147/cia.s85808 · Cited by 112
Inhibition of ??-Secretase as a Therapeutic Intervention for Alzheimer???s Disease
Evin, G. M., Sernee, M. F., & Masters, C. L. (2006) · CNS Drugs · doi:10.2165/00023210-200620050-00002 · Cited by 106
Is Alzheimer's disease related to metabolic syndrome? A Wnt signaling conundrum
Ríos, J. A., Cisternas, P., Arrese, M. A., Salesa Barja, Y., & Inestrosa, N. C. (2014) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2014.07.004 · Cited by 107
The Tottori (D7N) and English (H6R) Familial Alzheimer Disease Mutations Accelerate Aβ Fibril Formation without Increasing Protofibril Formation
Hori, Y., Hashimoto, T., Wakutani, Y., Urakami, K., Nakashima, K., Condron, M. M., Tsubuki, S., Saido, T. C., Teplow, D. B., & Iwatsubo, T. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m608220200 · Cited by 107
Tau negative frontal lobe dementia at 17q21: significant finemapping of the candidate region to a 4.8 cM interval
Rademakers, R., Cruts, M., Dermaut, B., Sleegers, K., Rosso, S. M., den Broeck, M. V., Backhovens, H., Swieten, J. C. V., van Duijn, C. M., & Broeckhoven, C. V. (2002) · Molecular Psychiatry · doi:10.1038/sj.mp.4001198 · Cited by 105
Ordered-Subsets Linkage Analysis Detects Novel Alzheimer Disease Loci on Chromosomes 2q34 and 15q22
Scott, W. K., Hauser, E. R., Schmechel, D. E., Welsh-Bohmer, K. A., Small, G. W., Roses, A. D., Saunders, A. M., Gilbert, J. R., Vance, J. M., Haines, J. L., et al. (2003) · The American Journal of Human Genetics · doi:10.1086/379083 · Cited by 105
Pooled-DNA sequencing identifies novel causative variants in PSEN1, GRN and MAPT in a clinical early-onset and familial Alzheimer's disease Ibero-American cohort
Jin, S. C., Pástor, P., Cooper, B., Cervantes, S., Benítez, B. A., Razquín, C., Goate, A., Ibero-American Alzheimer Disease Genetics Group Researchers, & Cruchaga, C. (2012) · Alzheimer s Research & Therapy · doi:10.1186/alzrt137 · Cited by 106
Hyperphosphorylated tau and paired helical filament-like structures in the brains of mice carrying mutant amyloid precursor protein and mutant presenilin-1 transgenes
Kurt, M. A. (2003) · Neurobiology of Disease · doi:10.1016/s0969-9961(03)00084-6 · Cited by 103
Alzheimer’s Disease and Cancer: When Two Monsters Cannot Be Together
Majd, S., Power, J., & Majd, Z. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00155 · Cited by 102
Overexpression in Neurons of Human Presenilin-1 or a Presenilin-1 Familial Alzheimer Disease Mutant Does Not Enhance Apoptosis
Bursztajn, S., DeSouza, R., McPhie, D. L., Berman, S. A., Shioi, J., Robakis, N. K. R. K., & Neve, R. L. (1998) · Journal of Neuroscience · doi:10.1523/jneurosci.18-23-09790.1998 · Cited by 102
ICE, neuronal apoptosis and neurodegeneration
Friedlander, R. M., & Yuan, J. (1998) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4400433 · Cited by 102
Epidemiology of the dementias: recent developments and new approaches.
van Duijn, C. M. (1996) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.60.5.478 · Cited by 102
Increased Aβ42(43) from cell lines expressing presenilin 1 mutations
Mehta, N. D., Refolo, L. M., Eckman, C., Sanders, S., Yager, D., Perez‐Tur, J., Younkin, S., Duff, K., Hardy, J., & Hutton, M. (1998) · Annals of Neurology · doi:10.1002/ana.410430217 · Cited by 101
Physical Exercise and Alzheimer’s Disease: Effects on Pathophysiological Molecular Pathways of the Disease
López‐Ortiz, S., Pinto-Fraga, J., Valenzuela, P. L., Martín-Hernández, J., Seisdedos, M. M., García, Ó., Toschi, N., Giuliano, F. D., Garaci, F. G., Mercuri, N. B., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22062897 · Cited by 107
Presenilin structure, function and role in Alzheimer disease
Fraser, P. E., Yang, D.-S., Yu, G., Lévesque, L., Nishimura, M., Arawaka, S., Serpell, L. C., Rogaeva, E. A., & George‐Hyslop, P. S. (2000) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/s0925-4439(00)00028-4 · Cited by 103
Transgenic mouse models of Alzheimer’s disease
Janus, C., Chishti, M. A., & Westaway, D. (2000) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/s0925-4439(00)00033-8 · Cited by 101
Alternate Aggregation Pathways of the Alzheimer β-Amyloid Peptide: Aβ Association Kinetics at Endosomal pH
Gorman, P. M., Yip, C. M., Fraser, P. E., & Chakrabartty, A. (2002) · Journal of Molecular Biology · doi:10.1016/s0022-2836(02)01279-2 · Cited by 100
Apolipoprotein E4 Stimulates cAMP Response Element-binding Protein Transcriptional Activity through the Extracellular Signal-regulated Kinase Pathway
Ohkubo, N., Mitsuda, N., Tamatani, M., Yamaguchi, A., Lee, Y., Ogihara, T., Vitek, M. P., & Tohyama, M. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m005070200 · Cited by 100
Increased Prevalence and Earlier Onset of Mood Disorders Among Relatives of Prepubertal Versus Adult Probands
Neuman, R. J., Geller, B., Rice, J. P., & Todd, R. D. (1997) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199704000-00008 · Cited by 100
Apolipoprotein E genotype in patients with alzheimer's disease: Implications for the risk of dementia among relatives
Farrer, L. A., Cupples, L. A., van Duijn, C. M., Kurz, A., Zimmer, R., Müller, U., Green, R. C., Clarke, V., Shoffner, J. M., Wallace, D. C., et al. (1995) · Annals of Neurology · doi:10.1002/ana.410380515 · Cited by 100
The role of large pedigrees in an era of high-throughput sequencing
Wijsman, E. M. (2012) · Human Genetics · doi:10.1007/s00439-012-1190-2 · Cited by 99
Self-citation
Stress as risk factor for Alzheimer’s disease
Caruso, A., Nicoletti, F., Mango, D., Saidi, A., Orlando, R., & Scaccianoce, S. (2018) · Pharmacological Research · doi:10.1016/j.phrs.2018.04.017 · Cited by 101
Genes and the Environment in Neurodegeneration
Coppedè, F., Mancuso, M., Siciliano, G., Migliore, L., & Murri, L. (2006) · Bioscience Reports · doi:10.1007/s10540-006-9028-6 · Cited by 100
The membrane-spanning 4-domains, subfamily A (MS4A) gene cluster contains a common variant associated with Alzheimer's disease
Antúnez, C., Boada, M., González‐Pérez, A., Gayán, J., Ramírez‐Lorca, R., Marín, J., Hernández, I., Moreno‐Rey, C., Morón, F. J., López‐Arrieta, J., et al. (2011) · Genome Medicine · doi:10.1186/gm249 · Cited by 100
A Turning Point in Schizophrenia Genetics
Karayiorgou, M., & Gogos, J. A. (1997) · Neuron · doi:10.1016/s0896-6273(00)80390-6 · Cited by 99
Presenilins interact with Rab11, a small GTPase involved in the regulation of vesicular transport
Dumanchin, C. (1999) · Human Molecular Genetics · doi:10.1093/hmg/8.7.1263 · Cited by 99
Neurodegeneration: diseases of the cytoskeleton?
McMurray, C. T. (2000) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4400764 · Cited by 99
Role of the Low-density Lipoprotein Receptor–Related Protein in β-Amyloid Metabolism and Alzheimer Disease
Hyman, B. T., Strickland, D. K., & Rebeck, G. W. (2000) · Archives of Neurology · doi:10.1001/archneur.57.5.646 · Cited by 98
Presenilins and Alzheimer's disease
Kim, T.-W., & Tanzi, R. E. (1997) · Current Opinion in Neurobiology · doi:10.1016/s0959-4388(97)80089-x · Cited by 97
Self-citation
Alzheimer’s disease: A clinical perspective and future nonhuman primate research opportunities
Haque, R. U., & Levey, A. I. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1912954116 · Cited by 99
The JNK/c-Jun cascade and Alzheimer's disease
Okazawa, H., & Estus, S. (2002) · American Journal of Alzheimer s Disease & Other Dementias® · doi:10.1177/153331750201700209 · Cited by 98
Genome-wide linkage disequilibrium mapping of late-onset Alzheimer’s disease in Finland
Hiltunen, M. O., Mannermaa, A., Thompson, D., Easton, D. F., Pirskanen, M. M., Helisalmi, S., Koivisto, A. M., Lehtovirta, M., Ryynänen, M., & Soininen, H. S. (2001) · Neurology · doi:10.1212/wnl.57.9.1663 · Cited by 97
A Genome Survey for Novel Alzheimer Disease Risk Loci: Results at 10-cM Resolution
Zubenko, G. S., Hughes, H. B., Stiffler, J. S., Hurtt, M. R., & Kaplan, B. B. (1998) · Genomics · doi:10.1006/geno.1998.5306 · Cited by 97
Multiple cellular and molecular mechanisms Are involved in human Aβ clearance by transplanted adult astrocytes
Pihlaja, R., Koistinaho, J., Kauppinen, R., Sandholm, J., Tanila, H., & Koistinaho, M. (2011) · Glia · doi:10.1002/glia.21212 · Cited by 96
Genetic Heterogeneity in Alzheimer Disease and Implications for Treatment Strategies
Dominantly Inherited Alzheimer Network, Ringman, J. M., Goate, A., Masters, C. L., Cairns, N. J., Danek, A., Graff-Radford, N., Ghetti, B., & Morris, J. C. (2014) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-014-0499-8 · Cited by 96
Genetic variants in Alzheimer disease — molecular and brain network approaches
Gaiteri, C., Mostafavi, S., Honey, C. J., Jager, P. L. D., & Bennett, D. A. (2016) · Nature Reviews Neurology · doi:10.1038/nrneurol.2016.84 · Cited by 97
Variant Alzheimer’s disease with spastic paraparesis
Verkkoniemi, A., Somer, M., Rinne, J. O., Myllykangas, L., Crook, R., Hardy, J., Viitanen, M. H., Kalimo, H., & Haltia, M. (2000) · Neurology · doi:10.1212/wnl.54.5.1103 · Cited by 96
Structure of β-amyloid fibrils and its relevance to their neurotoxicity: Implications for the pathogenesis of Alzheimer’s disease
Irie, K., Murakami, K., Masuda, Y., Morimoto, A., Ohigashi, H., Ohashi, R., Takegoshi, K., Nagao, M., Shimizu, T., & Shirasawa, T. (2005) · Journal of Bioscience and Bioengineering · doi:10.1263/jbb.99.437 · Cited by 104
Seladin-1 transcription is linked to neuronal degeneration in Alzheimer’s disease
Iivonen, S., Hiltunen, M., Alafuzoff, I. I., Mannermaa, A., Kerokoski, P., Puoliväli, J. T., Salminen, A., Helisalmi, S., & Soininen, H. S. (2002) · Neuroscience · doi:10.1016/s0306-4522(02)00180-x · Cited by 97
Biomarker-based dissection of neurodegenerative diseases
Olsson, B., Zetterberg, H., Hampel, H. J., & Blennow, K. (2011) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2011.04.006 · Cited by 102
Genetics of Alzheimer’s Disease
Ridge, P. G., Ebbert, M., & Kauwe, J. S. K. (2013) · BioMed Research International · doi:10.1155/2013/254954 · Cited by 104
Risk Factors in Late Adolescence for Young-Onset Dementia in Men
Nordström, P., Nordström, A., Eriksson, M., Wahlund, L., & Gustafson, Y. (2013) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2013.9079 · Cited by 98
Is Alzheimer's Disease a Disorder of Mitochondria-Associated Membranes?
Schon, E. A., & Área-Gómez, E. (2010) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-100495 · Cited by 98
Alzheimer's Disease and the Eye☆
Armstrong, R. A. (2009) · Journal of Optometry · doi:10.3921/joptom.2009.103 · Cited by 101
Evidence for a novel late-onset Alzheimer disease locus on chromosome 19p13.2.
Wijsman, E. M., Daw, E. W., Yu, C.-E., Payami, H., Steinbart, E. J., Nochlin, D., Conlon, E. M., Bird, T. D., & Schellenberg, G. D. (2004) · The American Journal of Human Genetics · doi:10.1086/423393 · Cited by 71
Self-citation
Animal Toxins as Therapeutic Tools to Treat Neurodegenerative Diseases
de Souza, J. M., Gonçalves, B. D. C., Gomez, M. V., Vieira, L. B., & Ribeiro, F. M. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00145 · Cited by 94
Trafficking and proteolytic processing of amyloid precursor protein and secretases in Alzheimer's disease development: An up-to-date review
Yuksel, M., & Tacal, Ö. (2019) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2019.172415 · Cited by 99
The presenilin protein family member SPE-4 localizes to an ER/Golgi derived organelle and is required for proper cytoplasmic partitioning during Caenorhabditis elegans spermatogenesis
Arduengo, P. M., Appleberry, O. K., Chuang, P., & L’Hernault, S. W. (1998) · Journal of Cell Science · doi:10.1242/jcs.111.24.3645 · Cited by 97
Association Between Angiotensin-Converting Enzyme and Alzheimer Disease
Farrer, L. A., Sherbatich, T., Keryanov, S. A., Коровайцева, Г. И., Rogaeva, E. A., Petruk, S., Premkumar, S., Moliaka, Y., Song, Y., Pei, Y., et al. (2000) · Archives of Neurology · doi:10.1001/archneur.57.2.210 · Cited by 94
Familial Alzheimer’s Disease Mutations Differentially Alter Amyloid β-Protein Oligomerization
Gessel, M. M., Bernstein, S. L., Kemper, M., Teplow, D. B., & Bowers, M. T. (2012) · ACS Chemical Neuroscience · doi:10.1021/cn300050d · Cited by 97
EEG alterations in non-demented individuals related to apolipoprotein E genotype and to risk of Alzheimer disease
Пономарева, Н. В., Коровайцева, Г. И., & Rogaev, E. I. (2007) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2006.12.019 · Cited by 96
Brain-derived neurotrophic factor gene polymorphisms and Alzheimer?s disease
Matsushita, S., Arai, H., Matsui, T., Yuzuriha, T., Urakami, K., Masaki, T., & Higuchi, S. (2004) · Journal of Neural Transmission · doi:10.1007/s00702-004-0210-3 · Cited by 93
Increased expression of the γ‐secretase components presenilin‐1 and nicastrin in activated astrocytes and microglia following traumatic brain injury
Nadler, Y., Alexandrovich, A. G., Grigoriadis, N., Hartmann, T., Rao, K. S. J., Shohami, E., & Stein, R. (2008) · Glia · doi:10.1002/glia.20638 · Cited by 97
Aberrant Splicing in the Presenilin-1 Intron 4 Mutation Causes Presenile Alzheimer's Disease by Increased A 42 Secretion
Jonghe, C. D., MarcCruts, Rogaeva, E. A., Tysoe, C. J., Singleton, A., Vanderstichele, H., Meschino, W. S., Dermaut, B., Vanderhoeven, I., Backhovens, H., et al. (1999) · Human Molecular Genetics · doi:10.1093/hmg/8.8.1529 · Cited by 95
Hippocampal proteomics defines pathways associated with memory decline and resilience in normal aging and Alzheimer’s disease mouse models
Neuner, S. M., Wilmott, L. A., Hoffmann, B. R., Mozhui, K., & Kaczorowski, C. C. (2016) · Behavioural Brain Research · doi:10.1016/j.bbr.2016.06.002 · Cited by 95
Murine models of brain aging and age-related neurodegenerative diseases
Jucker, M., & Ingram, D. K. (1997) · Behavioural Brain Research · doi:10.1016/s0166-4328(96)02243-7 · Cited by 93
Clinicopathological features of familial Alzheimer's disease associated with the M139V mutation in the presenilin 1 gene. Pedigree but not mutation specific age at onset provides evidence for a further genetic factor
Fox, N. (1997) · Brain · doi:10.1093/brain/120.3.491 · Cited by 93
Biomarkers in Neurodegenerative Diseases
Jeromin, A., & Bowser, R. (2017) · Advances in Neurobiology · doi:10.1007/978-3-319-57193-5_20 · Cited by 92
Amyloid-beta Alzheimer targets - protein processing, lipid rafts, and amyloid-beta pores.
Arbor, S., LaFontaine, M., & Cumbay, M. G. (2016) · Europe PMC (PubMed Central) · Cited by 94
A mutant PSEN1 causes dementia with lewy bodies and variant Alzheimer's disease
Ishikawa, A., Piao, Y., Miyashita, A., Kuwano, R., Onodera, O., Ohtake, H., Suzuki, M., Nishizawa, M., & Takahashi, H. (2005) · Annals of Neurology · doi:10.1002/ana.20393 · Cited by 93
AßT Amyloidogenesis: Unique, or Variation on a Systemic Theme
Kisilevsky, R., Fraser, P. E., & Benson, M. D. (1997) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.3109/10409239709082674 · Cited by 92
Clinical, Pathological, and Biochemical Spectrum of Alzheimer Disease Associated With PS-1 Mutations
Lleó, A., Berezovska, O., Growdon, J. H., & Hyman, B. T. (2004) · American Journal of Geriatric Psychiatry · doi:10.1097/00019442-200403000-00006 · Cited by 94
Intramembrane-cleaving aspartic proteases and disease: presenilins, signal peptide peptidase and their homologs
Martoglio, B., & Golde, T. E. (2003) · Human Molecular Genetics · doi:10.1093/hmg/ddg303 · Cited by 92
Genetic variability in the regulatory region of presenilin 1 associated with risk for Alzheimer's disease and variable expression
Theuns, J. (2000) · Human Molecular Genetics · doi:10.1093/hmg/9.3.325 · Cited by 94
Effects of SEL-12 presenilin on LIN-12 localization and function in Caenorhabditis elegans
Levitan, D. J., & Greenwald, I. (1998) · Development · doi:10.1242/dev.125.18.3599 · Cited by 92
APP Family Regulates Neuronal Excitability and Synaptic Plasticity but Not Neuronal Survival
Lee, S. H., Kang, J., Ho, A., Watanabe, H., Bolshakov, V. Y., & Shen, J. (2020) · Neuron · doi:10.1016/j.neuron.2020.08.011 · Cited by 97
Genetic susceptibility factors for Alzheimer's disease
Richard, F., & Amouyel, P. (2001) · European Journal of Pharmacology · doi:10.1016/s0014-2999(00)00903-1 · Cited by 92
Withanolide A and Asiatic Acid Modulate Multiple Targets Associated with Amyloid-β Precursor Protein Processing and Amyloid-β Protein Clearance
Patil, S. P., Maki, S., Khedkar, S. A., Rigby, A. C., & Chan, C. (2010) · Journal of Natural Products · doi:10.1021/np900633j · Cited by 92
Biological function of Presenilin and its role in AD pathogenesis
Zhang, S., Zhang, M., Cai, F., & Song, W. (2013) · Translational Neurodegeneration · doi:10.1186/2047-9158-2-15 · Cited by 97
Membrane Topology of γ-Secretase Component PEN-2
Crystal, A., Morais, V. A., Pierson, T. C., Pijak, D. S., Carlin, D., Lee, V. M. ‐., & Doms, R. W. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m213107200 · Cited by 98
Wide range in age of onset for chromosome 1‐related familial Alzheimer's disease
Bird, T. D., Levy‐Lahad, E., Poorkaj, P., Sharma, V., Nemens, E. J., Lahad, A., Lampe, T. H., & Schellenberg, G. D. (1996) · Annals of Neurology · doi:10.1002/ana.410400619 · Cited by 91
Self-citation
The length of Amyloid-β in Hereditary Cerebral Hemorrhage with Amyloidosis, Dutch Type
Castaño, E. M., Prelli, F., Soto, C. A., Beavis, R. C., Matsubara, E., Shoji, M., & Frangione, B. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.50.32185 · Cited by 91
A Second Locus for Very-Late-Onset Alzheimer Disease: A Genome Scan Reveals Linkage to 20p and Epistasis between 20p and the Amyloid Precursor Protein Region
Olson, J. M., Goddard, K. A. B., & Dudek, D. M. (2002) · The American Journal of Human Genetics · doi:10.1086/341034 · Cited by 91
The impact of Aβ-plaques on cortical cholinergic and non-cholinergic presynaptic boutons in alzheimer's disease-like transgenic mice
Hu, L., Wong, T. P., Côté, S. L., Bell, K. F. S., & Cuello, A. C. (2003) · Neuroscience · doi:10.1016/s0306-4522(03)00394-4 · Cited by 90
Copper imbalance in Alzheimer’s disease: Convergence of the chemistry and the clinic
Kepp, K. P., & Squitti, R. (2019) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2019.06.018 · Cited by 93
Alzheimer’s disease – the journey of a healthy brain into organ failure
Golde, T. E. (2022) · Molecular Neurodegeneration · doi:10.1186/s13024-022-00523-1 · Cited by 98
Ubiquilin 1 Modulates Amyloid Precursor Protein Trafficking and Aβ Secretion
Hiltunen, M. O., Lu, A., Thomas, A. V., Romano, D., Kim, M., Jones, P., Xie, Z., Kounnas, M. Z., Wagner, S. L., Berezovska, O., et al. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m603106200 · Cited by 92
Self-citation
An Overview of Genome-Wide Association Studies in Alzheimer’s Disease
Shen, L., & Jia, J. (2016) · Neuroscience Bulletin · doi:10.1007/s12264-016-0011-3 · Cited by 93
Association of the mitochondrial tRNAA4336G mutation with Alzheimer's and Parkinson's diseases
Egensperger, R., Kösel, S., Schnopp, N. M., Mehraein, P., & Graeber, M. B. (1997) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.1997.tb01301.x · Cited by 90
Neuronal Localization of Presenilin-1 and Association with Amyloid Plaques and Neurofibrillary Tangles in Alzheimer’s Disease
Busciglio, J. A., Hartmann, H., Lorenzo, A., Wong, C. W., Baumann, K., Sommer, B., Staufenbiel, M., & Yankner, B. A. (1997) · Journal of Neuroscience · doi:10.1523/jneurosci.17-13-05101.1997 · Cited by 91

Authors: Levy-Lahad, E., Wasco, W., Poorkaj, P., Romano, D. M., Oshima, J., Pettingell, W. H., Yu, C.-E., Jondro, P. D., Schmidt, S. D., Wang, K., Crowley, A. C., Fu, Y.-H., Guenette, S. Y., Galas, D., Nemens, E., Wijsman, E. M., Bird, T. D., Schellenberg, G. D., & Tanzi, R. E.
Affiliations: Geriatric Research Education, and Clinical Center (182B), Veterans Affairs Medical Center, Seattle, WA 98108, USA.
Massachusetts General Hospital (US)
United States Department of Veterans Affairs (US)
Darwin Molecular, Bothell, WA 98021, USA.
Genetics and Aging Unit, Massachusetts General Hospital, Charlestown, MA 02129, USA.
University of Washington (US)
ORCID: Oshima, Junko
Yu, Chang-en
Fu, Ying-Hui
Galas, David
Wijsman, Ellen M.
Bird, Thomas D.
Schellenberg, Gerard D.
Tanzi, Rudolph E.
Venue: Science
Publisher: American Association for the Advancement of Science (AAAS)
Published: 1995-08-18
Volume: 269
Issue: 5226
Pages: 973-977
ISSN: 0036-8075 (ISSN-L)
1095-9203
DOI: 10.1126/science.7638622
OpenAlex: W2083633251
Cited by: 2,577
References: 25
Citations by year: 2026: 17 · 2025: 46 · 2024: 66 · 2023: 47 · 2022: 43 · 2021: 65 · 2020: 84 · 2019: 72 · 2018: 65 · 2017: 77 · 2016: 90 · 2015: 63 · 2014: 78 · 2013: 82 · 2012: 83
FWCI: 99.06
Type: journal article
Language: en
Open access: closed
Locations: Science (publishedVersion)
PubMed (publishedVersion)
Funders: National Institutes of Health (5r01ag011899-03)
National Institute on Aging (AG0513C, R01AG011762, R01 AG 11762, R01-AG11899)
Topics: Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
Keywords: familial Alzheimer's disease, candidate genes, missense mutations, gene homology, pathogenic variants
MeSH terms: Adult, Aged, Alzheimer Disease, Amino Acid Sequence, Base Sequence, Chromosome Mapping, Chromosomes, Human, Pair 1, Cloning, Molecular, Female, Germany, Humans, Lod Score, Male, Membrane Proteins, Middle Aged, Molecular Sequence Data, Mutation, Pedigree, Gene Expression, Point Mutation, DNA, Complementary, Presenilin-2

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Candidate gene for the chromosome 1 familial Alzheimer’s disease locus

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks